>
>
Antiemetics Drugs Market - By Drug Type (Serotonin-Receptor Antagonists, Glucocorticoids, Anticholinergics, Dopamine Receptor Antagonists), Application (CINV, Gastroenteritis), Route of Administration, Distribution Channel – Global Forecast 2024 – 2032
Download Free PDF

Antiemetics Drugs Market
Get a free sample of this reportGet a free sample of this report Antiemetics Drugs Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 288
Countries covered: 23
Pages: 183
Download Free PDF
Antiemetics Drugs Market Size
Antiemetics Drugs Market size was valued at around USD 6.7 billion in 2023 and is estimated to grow at 5.6% CAGR from 2024 to 2032. Antiemetic drugs are medications used to prevent or alleviate nausea and vomiting. These symptoms can be caused by a variety of conditions, including motion sickness, gastrointestinal disorders, pregnancy, chemotherapy, radiation therapy, surgery, and certain medications. Antiemetic drugs work through different mechanisms to target the pathways in the brain and gastrointestinal tract that trigger nausea and vomiting.
The rising prevalence of nausea and vomiting-inducing conditions is a significant driver for the antiemetic drugs market. Conditions such as chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), and nausea associated with pregnancy are becoming more prevalent globally, impacting patient quality of life and increasing the demand for effective antiemetic medications. For instance, according to the American Association for Cancer Research, approximately 1,958,310 new cases of cancer were diagnosed in the U.S. in 2023, with an estimated 609,820 deaths attributed to the disease. This growing incidence of cancer, coupled with the increasing use of chemotherapy and radiation treatments worldwide, is expected to significantly boost the demand for antiemetics.
Furthermore, the growing availability of reimbursement and coverage for antiemetic drugs further propels market growth. As healthcare systems and insurance providers increasingly recognize the importance of managing nausea and vomiting, reimbursement policies are expanding to include more antiemetic medications. This increased access lowers financial barriers for patients, driving higher utilization rates and market expansion.
Antiemetics Drugs Market Trends
Antiemetics Drugs Market Analysis
Based on drug type, the market is divided into serotonin-receptor antagonists, anticholinergics, glucocorticoids, dopamine receptor antagonists, neurokinin receptor antagonists, antihistamines, and other drug types. The serotonin-receptor antagonists segment of the antiemetics drugs market is forecasted to reach USD 3.4 billion by 2032.
Based on application, the antiemetics drugs market is bifurcated into chemotherapy induced nausea and vomiting (CINV), gastroenteritis, postoperative nausea and vomiting (PONV), and other applications. The chemotherapy induced nausea and vomiting (CINV) segment accounted for USD 3.1 billion in 2023 primarily due to the high incidence of cancer and the critical need for effective management of chemotherapy-induced nausea and vomiting (CINV).
Based on route of administration, the antiemetics drugs market is bifurcated into oral, parenteral, and other routes of administration. The oral segment accounted for USD 4.1 billion in 2023.
Based on distribution channel, the antiemetics drugs market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment accounted for USD 3.4 billion in 2023.
The growth of the antiemetics drugs market in the U.S., projected to reach USD 4.2 billion by 2032.
The antiemetics drugs market in UK is expected to experience significant and promising growth from 2024 to 2032.
Japan antiemetics drugs market is anticipated to witness lucrative growth between 2024 – 2032.
The antiemetics drugs market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
Antiemetics Drugs Market Share
The antiemetics drugs industry is characterized by intense competition, involving both major global companies and smaller to medium-sized companies vying for market dominance. Key to market strategy is the consistent launch of innovative products utilizing various technologies. Major industry leaders play a significant role in driving innovation by making substantial investments in research and development. Moreover, strategic partnerships, acquisitions, and mergers play crucial roles in strengthening market positions and enhancing international presence.
Antiemetics Drugs Market Companies
Some of the eminent market participants operating in the antiemetics drugs industry include:
Antiemetics Drugs Industry News:
The antiemetics drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Drug Type
Market, By Application
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries: